Newsletter | July 28, 2021

07.28.21 -- How A Med Device Company Became A Drug Developer

 
Sponsor
Articles
The Collective Benefits Of A Collaborative CFO
 

Terry Coelho, CFO, works as a team member, not just a finance manager, at BioDelivery Sciences.

Teach The Mind By Inspiring The Heart
 

While many leaders have become fixated on improving their teams’ communications skills during COVID-19, they, instead, need to be focused on something quite different — something that is not always about the leader and the organization’s metrics.

From Fusion Energy To Med Device … To Drug Developer?
 

TAE Life Sciences wanted to create a combination product that brought together its neutron beam with a drug that delivers boron to cancer cells. But the company didn’t want to be in a position where it relied on another company for the drug needed.

Video
From Academia To The Biopharma C-Suite
 

We thought this executive virtual roundtable topic, “From Academia To The Biopharma C-Suite,” would help you learn from executives who took a less traditional path to becoming a biopharmaceutical leader. Perspectives are provided by Rahul Aras, Ph.D., CEO, Iterion Therapeutics, Steffen Mueller, Ph.D., cofounder and CSO, Codagenix, and Prem Premsrirut, M.D., Ph.D., CEO, Mirimus.

Web-Exclusive Content
ICER: FDA Has Failed In Its Responsibility To Protect Patients From Harm
 

A recent report from Bloomberg Intelligence was not kind to the FDA’s approval of aducanumab for the treatment of patients with Alzheimer’s. A white paper released by the group states the approval would be met with more questions than answers and could bring a loss of credibility to the regulatory agency. Now, the Institute for Clinical and Economic Review (ICER) has issued a statement on the approval, which is no kinder to the agency or its approval. 

July 2021 Digital Edition
 

Inside you will find more on:

  • CEO Features
  • Clinical Trials 
  • Funding Topics
  • Growth Challenges

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines
 

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.